This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Amgen Inc. (AMGN) advanced 1.96% to $330.75 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&amp;P 500 Index falling 0.67% to 7,353.61 and Dow Jones Industrial Average falling 0.65% to 49,363.88.
The stock's rise snapped a three-day losing streak.
Amgen Inc. closed 15.47% short of its 52-week high of $391.29, which the company reached on March 2nd.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson &amp; Johnson (JNJ) rose 0.47% to $230.00, Pfizer Inc. (PFE) rose 1.30% to $25.66, and AbbVie Inc. (ABBV) rose 2.08% to $213.76.
Trading volume (2.9 M) eclipsed its 50-day average volume of 2.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 19, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-19-26 1634ET

AMGN

LABU

Amgen Inc. (AMGN) shares rose 1.96% to $330.75 on a weak trading day for the market, breaking a three-day losing streak. Despite this gain, the stock remains 15.47% below its 52-week high of $391.29. Competitors like Johnson & Johnson, Pfizer, and AbbVie also saw gains, with trading volume surpassing its 50-day average.

MarketWatch Automated

Amgen

Direxion S&P Biotech Bull 3X

Proshares Ultra Nasdaq Biotech

Invesco Biotechnology & Genome ETF

VG Health

First Trust NYSE Arca Biotech Index Fd

VanEck Biotech ETF

Health Care Select Sector SPDR

Ark Genomic Revolution ETF

iShares Global Healthcare

iShares Biotechnology ETF

ALPS Medical Breakthrough

iShares US Pharma

SPDR S&P Biotech

Invesco Nasdaq Biotechnology ETF

S&P 500

Dow Jones Industrial Average

Johnson & Johnson

Pfizer

Abbvie

Factset Research

Amgen Inc. Stock Outperforms Competitors On Strong Trading Day